Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281034
Status:
COMPLETED
Last Update Posted:
2012-04-12
First Post:
2006-01-23
Brief Title:
OASIS STUDY Outcome Assessment Using SF-36 v2 in Stroke Patient StudyOASIS STUDY
Sponsor:
Kyorin Pharmaceutical CoLtd
Organization:
Kyorin Pharmaceutical CoLtd
Study Overview
Official Title:
Outcome Assessment Using SF-36 v2 in Stroke Patient StudyOASIS Study
Status:
COMPLETED
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 To survey the health-related quality of life using the SF-36v2 score of patients with chronic brain infarction in Japan
2 Chronic brain infarction in Japan is better than EUUSA
2 Chronic brain infarction in Japan is better than EUUSA
Detailed Description:
Period2005-2007
Observation Timebaseline 8week 24week
matters investigated
1 QOL determination using SF-36 v2
2 Age sex brain infarction type stroke severity modified Rankin scale side of stroke complication smoking alcohol dizziness-vertigo-presyncope-light headedness combination medicine subjective symptoms psychic symptoms rehabilitation recurrence evaluation of depression Japan-Stroke Scale JSS-D
Observation Timebaseline 8week 24week
matters investigated
1 QOL determination using SF-36 v2
2 Age sex brain infarction type stroke severity modified Rankin scale side of stroke complication smoking alcohol dizziness-vertigo-presyncope-light headedness combination medicine subjective symptoms psychic symptoms rehabilitation recurrence evaluation of depression Japan-Stroke Scale JSS-D
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| oasis-2007 | None | None | None |